← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
SCHULER JACK W
10% Owner | Director | Other
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001021412
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 5
- Purchases · 24M
- 13
- Average purchase
- $626.8K
- Median purchase
- $500.0K
- Gross purchase value
- $8.1M
Companies: Aspira Women's Health Inc. | BIODESIX INC
13 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-08-13 | BIODESIX INC | BDSX | 10% Owner | Other | $367.1K | Open filing |
| 2026-08-12 | BIODESIX INC | BDSX | 10% Owner | Other | $666.0K | Open filing |
| 2026-06-09 | Aspira Women's Health Inc. | AWHL | 10% Owner | $100.0K | Open filing |
| 2026-01-27 | BIODESIX INC | BDSX | 10% Owner | Other | $1.2M | Open filing |
| 2026-01-26 | BIODESIX INC | BDSX | 10% Owner | Other | $903.8K | Open filing |
| 2025-09-23 | BIODESIX INC | BDSX | Director | 10% Owner | $1,000.0K | Open filing |
| 2025-09-19 | Aspira Women's Health Inc. | AWHL | 10% Owner | $500.0K | Open filing |
| 2025-09-19 | BIODESIX INC | BDSX | Director | 10% Owner | $111.4K | Open filing |
| 2025-09-03 | BIODESIX INC | BDSX | Director | 10% Owner | $1.5M | Open filing |
| 2025-05-20 | BIODESIX INC | BDSX | Director | 10% Owner | $1.3M | Open filing |
| 2024-11-22 | BIODESIX INC | BDSX | Director | 10% Owner | $123.0K | Open filing |
| 2024-11-21 | BIODESIX INC | BDSX | Director | 10% Owner | $234.0K | Open filing |
| 2024-11-06 | BIODESIX INC | BDSX | Director | 10% Owner | $136.3K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 11Developing | 84.6% (11/13) | 90.9% (10/11) | +4.9% | +8.2% | -7.0% |
| 20D | 11Developing | 84.6% (11/13) | 63.6% (7/11) | +9.4% | +6.7% | -16.7% |
| 60D | 9Developing | 81.8% (9/11) | 33.3% (3/9) | -12.2% | -7.5% | -35.2% |
| 120D | 9Developing | 90.0% (9/10) | 66.7% (6/9) | +44.9% | +31.3% | -79.0% |
Research patterns
- First purchase in 12M
- 0/11
- Large purchase ≥ $100k
- 12/13
- Cluster buying · 15D
- 4/13
- Buying the dip
- 9/11
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.